Since 1970, psilocybin and psilocin have been listed with the DEA as Schedule I substances, the federal federal government's most restrictive class. Drugs On this category are thought to have a "substantial potential for abuse" in addition to "no accepted health-related use," according to the DEA. “Psilocybin is now getting explored in clinical